Synthorx, Inc.

Home » Synthorx, Inc.

IPO

Synthorx, Inc.

We are a biopharmaceutical company focused on prolonging and improving the lives of people with cancer and autoimmune disorders.

Symbol

THOR

Price Range
TBD

Anticipated Shares
TBD

Anticipated Date
TBD

Underwriters
Jefferies, Leerink Partners, Evercore ISI, H.C. Wainwright & Co.

To view the prospectus for Synthorx, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253